Advances in Systemic Lupus Erythematosus Education Center
Chloroquine Non-inferior to Methotrexate in Patients with Cutaneous Disease in SLE
March 23, 2022
Chloroquine may be non-inferior to methotrexate in achieving complete clinical response in the treatment of patients with cutaneous disease in systemic lupus erythematosus (SLE)...
Adding Voclosporin to Lupus Nephritis Treatment Proves Effective
June 17, 2022The addition of voclosporin to mycophenolate mofetil and low-dose steroids for the treatment of lupus nephritis resulted in improved protein-to-creatinine ratio...
Patients with Lupus at Increased Risk of MACE After Surgery
June 13, 2022Patients with systemic lupus erythematosus (SLE) who undergo noncardiac surgery face an increased risk of postoperative major adverse cardiac events (MACE)...
High-Dose Iberdomide Bests Placebo in Patients with SLE
April 6, 2022Patients who received 0.45mg doses of iberdomide saw a higher Systemic Lupus Erythematosus Responder Index response compared to placebo...
Clinical Trial Program for Baricitinib as a Lupus Treatment Discontinued
March 28, 2022The manufacturer of baricitinib announced it is discontinuing the phase 3 development program for the treatment of patients with active systemic lupus erythematosus, based on efficacy results from two trials...
Healthy Lifestyle Reduces Risk of Incident Systemic Lupus Erythematosus
October 15, 2021The risk of systematic lupus erythematous may be reduced by almost half by adhering to modifiable healthy lifestyle behaviors according to new research...
